SlideShare uma empresa Scribd logo
1 de 24
Baixar para ler offline
WHO's Mental Health
         Programme:
     Continuing Challenges
          Department of Mental Health and
                 Substance Abuse

             World Health Organization

                     Geneva




1|
Disease Burden (DALYs)


                 Maternal conditions       Perinatal conditions
                                               Nutritional deficiencies
              Respiratory infections
                      Malaria                   Other NCDs
       Childhood diseases                           Malignant neoplasms
                                                       Diabetes
     Diarrhoeal diseases

            HIV/AIDS
                                                           Neuropsychiatric disorders
         Tuberculosis

      Other CD causes                                     Sense organ disorders

                                                      Cardiovascular diseases
                        Injuries
              Congenital abnormalities     Respiratory diseases
                                         Digestive diseases
            Musculoskeletal diseases     Diseases of the genitourinary system
                                                                                  Source: WHR 2002

2|
Leading Causes of Mortality and Burden of Disease
                               world, 2004

                Mortality                                            DALYs
                                           %                                            %
1.      Ischaemic heart disease           12.2   1.     Lower respiratory infections    6.2

2.      Cerebrovascular disease            9.7   2.     Diarrhoeal diseases             4.8

3.      Lower respiratory infections       7.1   3.     Depression                      4.3

4.      COPD                               5.1   4.     Ischaemic heart disease         4.1

5.      Diarrhoeal diseases                3.7   5.     HIV/AIDS                        3.8

6.      HIV/AIDS                           3.5   6.     Cerebrovascular disease         3.1

7.      Tuberculosis                       2.5   7.     Prematurity, low birth weight   2.9

8.      Trachea, bronchus, lung cancers    2.3   8.     Birth asphyxia, birth trauma    2.7

9.      Road traffic accidents             2.2   9.     Road traffic accidents          2.7

10.     Prematurity, low birth weight      2.0   10.    Neonatal infections and other   2.7




       3|
Leading causes of disease burden for women aged
       15–44 years, high-income countries, and low-
            and middle-income countries, 2004




4|
2030 rankings:
           The leading causes of DALYs lost
 World                   1   HIV/AIDS
                         2   Depression
                         3   Ischaemic heart dis.


 High-income countries   1   Depression
                         2   Ischaemic heart disease
                         3   Alzheimer


 Middle-income countries 1   HIV/AIDS
                         2   Depression
                         3   Cerebrovascular


 Low-income countries    1   HIV/AIDS
                         2   Perinatal
                         3   Depression

5|
Scarcity
     Human Resources
       (N=157 to 183 countries)




6|
Burden versus Budget




7|
Gap in treatment:
  Serious cases receiving no treatment during the last 12 months
                  90


                  80                                                           85%
                  70                                             76%

                  60


                  50

                                                 50%
                  40


                  30               35%
                  20


                  10


                   0

                                 Lower range    Upper range      Lower range     Upper range



                              Developed countries             Developing countries
(WHO World Mental Health Consortium, JAMA, June 2nd 2004)



      8|
THE BURDEN OF MENTAL DISORDERS: Treatment
   gap for Schizophrenia and Mood Disorders

           Treatment              Treatment
             Gap                    Gap
             69%                    98%




          COVERAGE
                       COVERAGE




 9|
INEFFICIENT USE OF RESOURCES:
       High concentration of resources in mental hospitals




10 |
  Provide treatment in           Establish national policies,
          primary care                    programmes and legislation

         Make psychotropic drugs        Develop human resources
          available
                                         Link with other sectors
         Give care in the community
                                         Monitor community mental
         Educate the public              health

         Involve communities,           Support more research
          families and consumers


11 |
Impact of WHR-2001

Awareness                     +++

Understanding                 ++

Action                        +
12 |
Additional yearly investment on the package that will be needed per
  capita population to get from current to target coverage levels
                            (2006-2015)




13 |
mhGAP
    mental health Gap Action Programme
Scaling up care for mental, neurological and substance use disorders




 14 |
Mental Health Services (WHO, 2003)
        HIGH                                        LOW




                                Specialist
                                 Services
                                                           FREQUENCY
                                                            OF NEED
COST                     Psychiatric Community
                         Services in   Mental
                           General     Health
                          Hospitals   Services

                          Mental Health Services
                             through PHC

                       INFORMAL COMMUNITY CARE
        LOW
                                                    HIGH
                              SELF CARE



 15 |
mhGAP: Scaling Up Care

 Objectives
       – To achieve significantly higher coverage with
        key interventions for priority MNS conditions in
        resource-poor countries




16 |
17 |
18 |
19 |
20 |
21 |
22 |
WHO QualityRights
                    Improving quality and human rights in
              facilities and promoting a civil society movement




  Assessment of facilities


  Development of a change plan



  Capacity building on human rights issues



23 |
How can WHO Collaborative Centres help?

 Advocacy

 Demonstrating that community based models work

 Developing guidelines and manuals

 Publishing scientific evidence on effectiveness and
  cost

 Training professionals from other countries


24 |

Mais conteúdo relacionado

Destaque (9)

Introduction to DALY and burden of disease
Introduction to DALY and burden of diseaseIntroduction to DALY and burden of disease
Introduction to DALY and burden of disease
 
Mental health
Mental healthMental health
Mental health
 
Unit 5 epidemiology schizophrenia
Unit 5 epidemiology schizophreniaUnit 5 epidemiology schizophrenia
Unit 5 epidemiology schizophrenia
 
Schizophrenia (1)
Schizophrenia (1)Schizophrenia (1)
Schizophrenia (1)
 
epidemiology and etiology of schizophrenia dsm5
epidemiology and etiology of schizophrenia dsm5epidemiology and etiology of schizophrenia dsm5
epidemiology and etiology of schizophrenia dsm5
 
Schizophrenia
SchizophreniaSchizophrenia
Schizophrenia
 
Schizophrenia Presentation
Schizophrenia PresentationSchizophrenia Presentation
Schizophrenia Presentation
 
Schizophrenia
SchizophreniaSchizophrenia
Schizophrenia
 
Schizophrenia (1)
Schizophrenia (1)Schizophrenia (1)
Schizophrenia (1)
 

Semelhante a Cooperare per la salute - Mezzina - Parte 2

Non-communicable disease and the future of development
Non-communicable disease and the future of developmentNon-communicable disease and the future of development
Non-communicable disease and the future of development
Jeff Knezovich
 
Andrea Peracino
Andrea PeracinoAndrea Peracino
Andrea Peracino
agrilinea
 
Learning from low and middle income countries about responding to non-communi...
Learning from low and middle income countries about responding to non-communi...Learning from low and middle income countries about responding to non-communi...
Learning from low and middle income countries about responding to non-communi...
University of warwick
 
World Alzheimer Report 2011 - ADI
World Alzheimer Report 2011 - ADIWorld Alzheimer Report 2011 - ADI
World Alzheimer Report 2011 - ADI
Zoely Mamizaka
 
Presentation on Dementia .Dementia in Bangladesh.pptx
Presentation on Dementia .Dementia in Bangladesh.pptxPresentation on Dementia .Dementia in Bangladesh.pptx
Presentation on Dementia .Dementia in Bangladesh.pptx
Motahar Alam
 
Utah’s All Payer Claims Dataset: A vital resource for health reform
Utah’s All Payer Claims Dataset: A  vital resource for health reformUtah’s All Payer Claims Dataset: A  vital resource for health reform
Utah’s All Payer Claims Dataset: A vital resource for health reform
State of Utah, Salt Lake City
 

Semelhante a Cooperare per la salute - Mezzina - Parte 2 (20)

Non-communicable disease and the future of development
Non-communicable disease and the future of developmentNon-communicable disease and the future of development
Non-communicable disease and the future of development
 
Introduction: Richard Smith
Introduction: Richard SmithIntroduction: Richard Smith
Introduction: Richard Smith
 
Andrea Peracino
Andrea PeracinoAndrea Peracino
Andrea Peracino
 
CCIH 2012 Conference, Plenary 2, Jonathan Quick, Janneke Quick, Chronic Disea...
CCIH 2012 Conference, Plenary 2, Jonathan Quick, Janneke Quick, Chronic Disea...CCIH 2012 Conference, Plenary 2, Jonathan Quick, Janneke Quick, Chronic Disea...
CCIH 2012 Conference, Plenary 2, Jonathan Quick, Janneke Quick, Chronic Disea...
 
Learning from low and middle income countries about responding to non-communi...
Learning from low and middle income countries about responding to non-communi...Learning from low and middle income countries about responding to non-communi...
Learning from low and middle income countries about responding to non-communi...
 
Session 2: Carol Brayne
Session 2: Carol Brayne Session 2: Carol Brayne
Session 2: Carol Brayne
 
World Alzheimer Report 2011 - ADI
World Alzheimer Report 2011 - ADIWorld Alzheimer Report 2011 - ADI
World Alzheimer Report 2011 - ADI
 
Aridhia at the 4th Big Data Insight Group Forum
Aridhia at the 4th Big Data Insight Group ForumAridhia at the 4th Big Data Insight Group Forum
Aridhia at the 4th Big Data Insight Group Forum
 
Depression feb2012
Depression feb2012Depression feb2012
Depression feb2012
 
Συχνότερα χρόνια νοσήματα, καταστάσεις υγείας, συχνότερα συμπτώματα στην κοιν...
Συχνότερα χρόνια νοσήματα, καταστάσεις υγείας, συχνότερα συμπτώματα στην κοιν...Συχνότερα χρόνια νοσήματα, καταστάσεις υγείας, συχνότερα συμπτώματα στην κοιν...
Συχνότερα χρόνια νοσήματα, καταστάσεις υγείας, συχνότερα συμπτώματα στην κοιν...
 
Scaling up mental health care: a framework for action
Scaling up mental health care: a framework for actionScaling up mental health care: a framework for action
Scaling up mental health care: a framework for action
 
Dr Ashoo Grover
Dr Ashoo GroverDr Ashoo Grover
Dr Ashoo Grover
 
Mobilizing Women in the Fight Against NCDs
Mobilizing Women in the Fight Against NCDsMobilizing Women in the Fight Against NCDs
Mobilizing Women in the Fight Against NCDs
 
Presentation on Dementia .Dementia in Bangladesh.pptx
Presentation on Dementia .Dementia in Bangladesh.pptxPresentation on Dementia .Dementia in Bangladesh.pptx
Presentation on Dementia .Dementia in Bangladesh.pptx
 
Non communicable diseases (final)
Non communicable diseases (final)Non communicable diseases (final)
Non communicable diseases (final)
 
Epilepsia
EpilepsiaEpilepsia
Epilepsia
 
Utah’s All Payer Claims Dataset: A vital resource for health reform
Utah’s All Payer Claims Dataset: A  vital resource for health reformUtah’s All Payer Claims Dataset: A  vital resource for health reform
Utah’s All Payer Claims Dataset: A vital resource for health reform
 
Palliative and end of life care
Palliative and end of life carePalliative and end of life care
Palliative and end of life care
 
Jowett matthew - Innovation in other sectors
Jowett matthew - Innovation in other sectorsJowett matthew - Innovation in other sectors
Jowett matthew - Innovation in other sectors
 
Goal4.org
Goal4.orgGoal4.org
Goal4.org
 

Mais de Area Welfare di Comunità - Ass5 Bassa Friulana

Mais de Area Welfare di Comunità - Ass5 Bassa Friulana (20)

Infoday settembre 2014 - Associazionismo Familiare
Infoday settembre 2014 - Associazionismo FamiliareInfoday settembre 2014 - Associazionismo Familiare
Infoday settembre 2014 - Associazionismo Familiare
 
Seminario “SUPERARE IL PRIMO STEP PER PARTIRE” Sacile 3 aprile - Giovanni Bel...
Seminario “SUPERARE IL PRIMO STEP PER PARTIRE” Sacile 3 aprile - Giovanni Bel...Seminario “SUPERARE IL PRIMO STEP PER PARTIRE” Sacile 3 aprile - Giovanni Bel...
Seminario “SUPERARE IL PRIMO STEP PER PARTIRE” Sacile 3 aprile - Giovanni Bel...
 
Seminario “SUPERARE IL PRIMO STEP PER PARTIRE” Sacile 3 aprile - Carlo Zanin
Seminario “SUPERARE IL PRIMO STEP PER PARTIRE” Sacile 3 aprile - Carlo ZaninSeminario “SUPERARE IL PRIMO STEP PER PARTIRE” Sacile 3 aprile - Carlo Zanin
Seminario “SUPERARE IL PRIMO STEP PER PARTIRE” Sacile 3 aprile - Carlo Zanin
 
Foto convegno fundraising udine 2 marzo 2013
Foto convegno fundraising   udine 2 marzo 2013Foto convegno fundraising   udine 2 marzo 2013
Foto convegno fundraising udine 2 marzo 2013
 
Servizio famiglia pn 12.10.12
Servizio famiglia pn 12.10.12Servizio famiglia pn 12.10.12
Servizio famiglia pn 12.10.12
 
Irsses.pn 12.10.12
Irsses.pn 12.10.12Irsses.pn 12.10.12
Irsses.pn 12.10.12
 
Slide professoressa Carrà - Centro di Ateneo Studi e Ricerche sulla Famiglia
Slide professoressa Carrà - Centro di Ateneo Studi e Ricerche sulla FamigliaSlide professoressa Carrà - Centro di Ateneo Studi e Ricerche sulla Famiglia
Slide professoressa Carrà - Centro di Ateneo Studi e Ricerche sulla Famiglia
 
Slide Area Welfare di comunità ASS n. 5
Slide Area Welfare di comunità ASS n. 5Slide Area Welfare di comunità ASS n. 5
Slide Area Welfare di comunità ASS n. 5
 
Meeting nassfeld
Meeting nassfeldMeeting nassfeld
Meeting nassfeld
 
Associazionismo familiare
Associazionismo familiareAssociazionismo familiare
Associazionismo familiare
 
Descrizione bando associazionismo familiare
Descrizione bando associazionismo familiareDescrizione bando associazionismo familiare
Descrizione bando associazionismo familiare
 
Cooperare per la salute - Taylor BILISTICK
Cooperare per la salute - Taylor BILISTICKCooperare per la salute - Taylor BILISTICK
Cooperare per la salute - Taylor BILISTICK
 
Cooperare per la salute - Fanizza
Cooperare per la salute - FanizzaCooperare per la salute - Fanizza
Cooperare per la salute - Fanizza
 
WORKSHOP 9 DIC 2011 - Carditalia
WORKSHOP 9 DIC 2011 - CarditaliaWORKSHOP 9 DIC 2011 - Carditalia
WORKSHOP 9 DIC 2011 - Carditalia
 
WORKSHOP 9 DIC 2011 - Pletti
WORKSHOP 9 DIC 2011 - PlettiWORKSHOP 9 DIC 2011 - Pletti
WORKSHOP 9 DIC 2011 - Pletti
 
WORKSHOP 9 DIC 2011 - Eldy Fonda
WORKSHOP 9 DIC 2011 - Eldy FondaWORKSHOP 9 DIC 2011 - Eldy Fonda
WORKSHOP 9 DIC 2011 - Eldy Fonda
 
WORKSHOP 9 DIC 2011 - Progetto presto a casa
WORKSHOP 9 DIC 2011 - Progetto presto a casaWORKSHOP 9 DIC 2011 - Progetto presto a casa
WORKSHOP 9 DIC 2011 - Progetto presto a casa
 
WORKSHOP 9 DIC 2011 - Fanizza
WORKSHOP 9 DIC 2011 - FanizzaWORKSHOP 9 DIC 2011 - Fanizza
WORKSHOP 9 DIC 2011 - Fanizza
 
WORKSHOP 9 DIC 2011 - Apuzzo
WORKSHOP 9 DIC 2011 - ApuzzoWORKSHOP 9 DIC 2011 - Apuzzo
WORKSHOP 9 DIC 2011 - Apuzzo
 
WORKSHOP 9 DIC 2011 - Torelli
WORKSHOP 9 DIC 2011 - TorelliWORKSHOP 9 DIC 2011 - Torelli
WORKSHOP 9 DIC 2011 - Torelli
 

Último

Último (20)

Is Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptxIs Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptx
 
MRI Artifacts and Their Remedies/Corrections.pptx
MRI Artifacts and Their Remedies/Corrections.pptxMRI Artifacts and Their Remedies/Corrections.pptx
MRI Artifacts and Their Remedies/Corrections.pptx
 
Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPTAntiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
 
A thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptxA thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptx
 
NCLEX RN REVIEW EXAM CONTENT BLUE BOOK PDF
NCLEX RN REVIEW EXAM CONTENT BLUE BOOK PDFNCLEX RN REVIEW EXAM CONTENT BLUE BOOK PDF
NCLEX RN REVIEW EXAM CONTENT BLUE BOOK PDF
 
SURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptx
SURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptxSURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptx
SURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptx
 
Why invest into infodemic management in health emergencies
Why invest into infodemic management in health emergenciesWhy invest into infodemic management in health emergencies
Why invest into infodemic management in health emergencies
 
Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...
 
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
 
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptxCURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
 
hypo and hyper thyroidism final lecture.pptx
hypo and hyper thyroidism  final lecture.pptxhypo and hyper thyroidism  final lecture.pptx
hypo and hyper thyroidism final lecture.pptx
 
รายการตํารับยาแผนไทยแห่งชาติ ฉบับ พ.ศ. 2564.pdf
รายการตํารับยาแผนไทยแห่งชาติ ฉบับ พ.ศ. 2564.pdfรายการตํารับยาแผนไทยแห่งชาติ ฉบับ พ.ศ. 2564.pdf
รายการตํารับยาแผนไทยแห่งชาติ ฉบับ พ.ศ. 2564.pdf
 
In-service education (Nursing Mangement)
In-service education (Nursing Mangement)In-service education (Nursing Mangement)
In-service education (Nursing Mangement)
 
The Orbit & its contents by Dr. Rabia I. Gandapore.pptx
The Orbit & its contents by Dr. Rabia I. Gandapore.pptxThe Orbit & its contents by Dr. Rabia I. Gandapore.pptx
The Orbit & its contents by Dr. Rabia I. Gandapore.pptx
 
CT scan of penetrating abdominopelvic trauma
CT scan of penetrating abdominopelvic traumaCT scan of penetrating abdominopelvic trauma
CT scan of penetrating abdominopelvic trauma
 
DECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptxDECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptx
 
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
 
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.GawadHemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
 
Cardiovascular Physiology - Regulation of Cardiac Pumping
Cardiovascular Physiology - Regulation of Cardiac PumpingCardiovascular Physiology - Regulation of Cardiac Pumping
Cardiovascular Physiology - Regulation of Cardiac Pumping
 
Scleroderma: Treatment Options and a Look to the Future - Dr. Macklin
Scleroderma: Treatment Options and a Look to the Future - Dr. MacklinScleroderma: Treatment Options and a Look to the Future - Dr. Macklin
Scleroderma: Treatment Options and a Look to the Future - Dr. Macklin
 

Cooperare per la salute - Mezzina - Parte 2

  • 1. WHO's Mental Health Programme: Continuing Challenges Department of Mental Health and Substance Abuse World Health Organization Geneva 1|
  • 2. Disease Burden (DALYs) Maternal conditions Perinatal conditions Nutritional deficiencies Respiratory infections Malaria Other NCDs Childhood diseases Malignant neoplasms Diabetes Diarrhoeal diseases HIV/AIDS Neuropsychiatric disorders Tuberculosis Other CD causes Sense organ disorders Cardiovascular diseases Injuries Congenital abnormalities Respiratory diseases Digestive diseases Musculoskeletal diseases Diseases of the genitourinary system Source: WHR 2002 2|
  • 3. Leading Causes of Mortality and Burden of Disease world, 2004 Mortality DALYs % % 1.  Ischaemic heart disease 12.2 1.  Lower respiratory infections 6.2 2.  Cerebrovascular disease 9.7 2.  Diarrhoeal diseases 4.8 3.  Lower respiratory infections 7.1 3.  Depression 4.3 4.  COPD 5.1 4.  Ischaemic heart disease 4.1 5.  Diarrhoeal diseases 3.7 5.  HIV/AIDS 3.8 6.  HIV/AIDS 3.5 6.  Cerebrovascular disease 3.1 7.  Tuberculosis 2.5 7.  Prematurity, low birth weight 2.9 8.  Trachea, bronchus, lung cancers 2.3 8.  Birth asphyxia, birth trauma 2.7 9.  Road traffic accidents 2.2 9.  Road traffic accidents 2.7 10.  Prematurity, low birth weight 2.0 10.  Neonatal infections and other 2.7 3|
  • 4. Leading causes of disease burden for women aged 15–44 years, high-income countries, and low- and middle-income countries, 2004 4|
  • 5. 2030 rankings: The leading causes of DALYs lost World 1 HIV/AIDS 2 Depression 3 Ischaemic heart dis. High-income countries 1 Depression 2 Ischaemic heart disease 3 Alzheimer Middle-income countries 1 HIV/AIDS 2 Depression 3 Cerebrovascular Low-income countries 1 HIV/AIDS 2 Perinatal 3 Depression 5|
  • 6. Scarcity Human Resources (N=157 to 183 countries) 6|
  • 8. Gap in treatment: Serious cases receiving no treatment during the last 12 months 90 80 85% 70 76% 60 50 50% 40 30 35% 20 10 0 Lower range Upper range Lower range Upper range Developed countries Developing countries (WHO World Mental Health Consortium, JAMA, June 2nd 2004) 8|
  • 9. THE BURDEN OF MENTAL DISORDERS: Treatment gap for Schizophrenia and Mood Disorders Treatment Treatment Gap Gap 69% 98% COVERAGE COVERAGE 9|
  • 10. INEFFICIENT USE OF RESOURCES: High concentration of resources in mental hospitals 10 |
  • 11.   Provide treatment in   Establish national policies, primary care programmes and legislation   Make psychotropic drugs   Develop human resources available   Link with other sectors   Give care in the community   Monitor community mental   Educate the public health   Involve communities,   Support more research families and consumers 11 |
  • 12. Impact of WHR-2001 Awareness +++ Understanding ++ Action + 12 |
  • 13. Additional yearly investment on the package that will be needed per capita population to get from current to target coverage levels (2006-2015) 13 |
  • 14. mhGAP mental health Gap Action Programme Scaling up care for mental, neurological and substance use disorders 14 |
  • 15. Mental Health Services (WHO, 2003) HIGH LOW Specialist Services FREQUENCY OF NEED COST Psychiatric Community Services in Mental General Health Hospitals Services Mental Health Services through PHC INFORMAL COMMUNITY CARE LOW HIGH SELF CARE 15 |
  • 16. mhGAP: Scaling Up Care  Objectives – To achieve significantly higher coverage with key interventions for priority MNS conditions in resource-poor countries 16 |
  • 17. 17 |
  • 18. 18 |
  • 19. 19 |
  • 20. 20 |
  • 21. 21 |
  • 22. 22 |
  • 23. WHO QualityRights Improving quality and human rights in facilities and promoting a civil society movement   Assessment of facilities   Development of a change plan   Capacity building on human rights issues 23 |
  • 24. How can WHO Collaborative Centres help?  Advocacy  Demonstrating that community based models work  Developing guidelines and manuals  Publishing scientific evidence on effectiveness and cost  Training professionals from other countries 24 |